{"id":15245,"date":"2026-09-22T09:32:59","date_gmt":"2026-09-22T09:32:59","guid":{"rendered":"https:\/\/www.totarolchina.com\/?p=15245"},"modified":"2026-09-22T09:33:00","modified_gmt":"2026-09-22T09:33:00","slug":"bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters","status":"publish","type":"post","link":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/","title":{"rendered":"\u30d0\u30af\u30c1\u30aa\u30fc\u30eb vs PDRN\uff1a\u81e8\u5e8a\u52b9\u679c\u3068\u88fd\u5264\u30d1\u30e9\u30e1\u30fc\u30bf"},"content":{"rendered":"
\n

\n \u771f\u76ae\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u306e\u518d\u69cb\u7bc9\u306f\u5f53\u3066\u305a\u3063\u307d\u3046\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u305d\u308c\u306f\u7279\u5b9a\u306e\u751f\u5316\u5b66\u7684\u7d4c\u8def\u306b\u4f9d\u5b58\u3057\u307e\u3059\u3002\u6d3b\u6027\u5206\u5b50\u3092\u5c0e\u5165\u3059\u308b\u3068\u3001\u76ae\u819a\u304c\u53cd\u5fdc\u3057\u307e\u3059\u3002\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306f\u30ec\u30c1\u30ce\u30fc\u30eb\u3092\u6a21\u5023\u3057\u307e\u3059\u3002PDRN\u306f\u30a2\u30c7\u30ce\u30b7\u30f3\u53d7\u5bb9\u4f53\u3092\u4ecb\u3057\u3066\u7d44\u7e54\u3092\u518d\u751f\u3057\u307e\u3059\u30022\u3064\u306e\u7570\u306a\u308b\u30e1\u30ab\u30cb\u30ba\u30e0\u3002\u305d\u308c\u3089\u306e\u7269\u7406\u5316\u5b66\u7684\u7279\u6027\u3092\u4e26\u3079\u3066\u8a55\u4fa1\u3059\u308b\u3068\u3001\u5b9f\u969b\u306e\u88fd\u5264\u4e0a\u306e\u5236\u7d04\u304c\u660e\u3089\u304b\u306b\u306a\u308a\u307e\u3059\u3002\u30cf\u30fc\u30c9\u30c7\u30fc\u30bf\u3092\u898b\u3066\u307f\u307e\u3057\u3087\u3046\u3002\n <\/p>\n\n

\u7d4c\u8def\u6d3b\u6027\u5316\u3068\u81e8\u5e8a\u7684\u73fe\u5b9f<\/h2>\n\n

\n \u306a\u305c\u4e00\u65b9\u3067\u306f\u306a\u304f\u4ed6\u65b9\u3092\u9078\u3076\u306e\u304b\uff1f\u30e1\u30ab\u30cb\u30ba\u30e0\u304c\u9069\u7528\u65b9\u6cd5\u3092\u6c7a\u5b9a\u3057\u307e\u3059\u3002\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306f\u3001\u771f\u76ae\u8868\u76ae\u63a5\u5408\u90e8\u306e\u69cb\u9020\u7684\u52a3\u5316\u3092\u6a19\u7684\u3068\u3057\u307e\u3059\u3002CRBP-1\u3084RARE\u306e\u3088\u3046\u306a\u30ec\u30c1\u30ce\u30fc\u30eb\u8a98\u5c0e\u907a\u4f1d\u5b50\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u30a2\u30c3\u30d7\u30ec\u30ae\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u30ec\u30c1\u30ce\u30a4\u30f3\u9178\u53d7\u5bb9\u4f53\u306b\u89e6\u308c\u308b\u3053\u3068\u306a\u304f\u884c\u308f\u308c\u307e\u3059\u3002\u5178\u578b\u7684\u306a\u30ec\u30c1\u30ce\u30a4\u30c9\u306e\u708e\u75c7\u30ab\u30b9\u30b1\u30fc\u30c9\u3092\u56de\u907f\u3057\u307e\u3059\u3002 \u81e8\u5e8a\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\u3067\u306f\u30010.5%\u306e\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u30a8\u30de\u30eb\u30b8\u30e7\u30f3\u304c\u30011\u65e52\u56de\u306e\u5857\u5e03\u309212\u9031\u9593\u884c\u3063\u305f\u7d50\u679c\u3001\u3057\u308f\u306e\u6df1\u3055\u309220.5%\u8efd\u6e1b\u3057\u3001\u8272\u7d20\u6c88\u7740\u306e\u5f37\u5ea6\u309259%\u6e1b\u5c11\u3055\u305b\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/strong>[\u30d6\u30ea\u30c6\u30a3\u30c3\u30b7\u30e5\u30fb\u30b8\u30e3\u30fc\u30ca\u30eb\u30fb\u30aa\u30d6\u30fb\u30c0\u30fc\u30de\u30c8\u30ed\u30b8\u30fc\uff1a\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306b\u3088\u308b\u76ae\u819a\u8001\u5316\u7279\u6027\u306e\u8a55\u4fa1 \u2013 https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/bjd.16918]<\/span> \n <\/p>\n\n

\n PDRN\u306f\u7570\u306a\u308b\u50cd\u304d\u3092\u3057\u307e\u3059\u3002\u30b5\u30eb\u30d9\u30fc\u30b8\u7d4c\u8def\u3092\u4ecb\u3057\u3066\u6a5f\u80fd\u3057\u307e\u3059\u3002DNA\u5408\u6210\u306e\u305f\u3081\u306e\u7279\u5b9a\u306e\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u524d\u99c6\u4f53\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u30a2\u30c7\u30ce\u30b7\u30f3A2A\u53d7\u5bb9\u4f53\u306b\u9078\u629e\u7684\u306b\u7d50\u5408\u3057\u307e\u3059\u3002\u3053\u306e\u7d50\u5408\u306f\u8840\u7ba1\u5185\u76ae\u5897\u6b96\u56e0\u5b50\uff08VEGF\uff09\u306e\u653e\u51fa\u3092\u30c8\u30ea\u30ac\u30fc\u3057\u307e\u3059\u3002\u7dda\u7dad\u82bd\u7d30\u80de\u306e\u5897\u6b96\u304c\u6025\u5897\u3057\u307e\u3059\u3002 invitro\u7d30\u80de\u751f\u5b58\u7387\u30a2\u30c3\u30bb\u30a4\u3067\u306f\u3001100 \u03bcg\/mL\u306ePDRN\u304c\u3001\u5bfe\u7167\u7fa4\u3068\u6bd4\u8f03\u3057\u306648\u6642\u9593\u4ee5\u5185\u306b\u30d2\u30c8\u771f\u76ae\u7dda\u7dad\u82bd\u7d30\u80de\u306e\u751f\u5b58\u7387\u309232%\u5897\u52a0\u3055\u305b\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/strong>[\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\u30fb\u30b8\u30e3\u30fc\u30ca\u30eb\u30fb\u30aa\u30d6\u30fb\u30e2\u30ec\u30ad\u30e5\u30e9\u30fc\u30fb\u30b5\u30a4\u30a8\u30f3\u30b7\u30ba\uff1a\u30dd\u30ea\u30c7\u30aa\u30ad\u30b7\u30ea\u30dc\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\uff08PDRN\uff09\u306f\u5275\u50b7\u6cbb\u7652\u3092\u4fc3\u9032\u3059\u308b \u2013 https:\/\/www.mdpi.com\/1422-0067\/17\/3\/350]<\/span> \u5275\u50b7\u6cbb\u7652\u3092\u52a0\u901f\u3057\u307e\u3059\u3002\u771f\u76ae\u3092\u539a\u304f\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u8868\u9762\u306e\u5fae\u8abf\u6574\u3067\u306f\u306a\u304f\u3001\u57fa\u672c\u7684\u306a\u7d44\u7e54\u4fee\u5fa9\u3067\u3059\u3002\n <\/p>\n\n

\u4ed5\u69d8\u30d1\u30e9\u30e1\u30fc\u30bf\u3068COA\u30d9\u30f3\u30c1\u30de\u30fc\u30af<\/h2>\n\n

\n \u54c1\u8cea\u7ba1\u7406\u306b\u306f\u5fb9\u5e95\u7684\u306a\u5206\u6790\u8a66\u9a13\u304c\u5fc5\u8981\u3067\u3059\u3002\u30d7\u30ec\u30df\u30a2\u30e0\u30b0\u30ec\u30fc\u30c9\u306e\u539f\u6750\u6599\u306f\u3053\u308c\u3089\u306e\u57fa\u6e96\u3092\u6e80\u305f\u3059\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u3053\u3067\u306f\u59a5\u5354\u306f\u8a31\u3055\u308c\u307e\u305b\u3093\u3002\n <\/p>\n\n

\n \n \n \n \n \n \n \n \n \n
\u8a66\u9a13\u9805\u76ee<\/th>\n \u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u30d1\u30e9\u30e1\u30fc\u30bf<\/th>\n PDRN\uff08\u30dd\u30ea\u30c7\u30aa\u30ad\u30b7\u30ea\u30dc\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\uff09<\/th>\n \u8a66\u9a13\u65b9\u6cd5\/\u5099\u8003<\/th>\n <\/tr>\n <\/thead>\n
\u5916\u89b3<\/td>\n \u9ec4\u8272\u304b\u3089\u8336\u8272\u306e\u7c98\u6027\u6db2\u4f53<\/td>\n \u767d\u8272\u304b\u3089\u30aa\u30d5\u30db\u30ef\u30a4\u30c8\u306e\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b<\/td>\n \u76ee\u8996\u691c\u67fb<\/td>\n <\/tr>\n
\u7d14\u5ea6\/\u30a2\u30c3\u30bb\u30a4<\/td>\n 99.0%\u4ee5\u4e0a<\/td>\n \u2265 95.0%\uff08DNA\u542b\u6709\u91cf\uff09<\/td>\n HPLC \/ UV\u5206\u5149\u5149\u5ea6\u6cd5<\/td>\n <\/tr>\n
\u5206\u5b50\u91cf<\/td>\n 256.38 g\/mol<\/td>\n 50 kDa \u2013 1500 kDa\uff08\u30dd\u30ea\u30de\u30fc\uff09<\/td>\n \u30b2\u30eb\u6d78\u900f\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u30fc<\/td>\n <\/tr>\n
\u6eb6\u89e3\u6027<\/td>\n \u975e\u5e38\u306b\u6cb9\u6eb6\u6027\u3001\u6c34\u4e0d\u6eb6\u6027<\/td>\n \u975e\u5e38\u306b\u6c34\u6eb6\u6027\u3001\u8102\u8cea\u4e0d\u6eb6\u6027<\/td>\n USP\u57fa\u6e96<\/td>\n <\/tr>\n
\u30bd\u30e9\u30ec\u30f3\u542b\u6709\u91cf<\/td>\n 1 ppm\u672a\u6e80<\/td>\n N\/A<\/td>\n \u5149\u5b89\u5168\u6027\u306b\u4e0d\u53ef\u6b20<\/td>\n <\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n\n

\u88fd\u5264\u4e0a\u306e\u5236\u7d04\uff1a\u30e9\u30dc\u306e\u73fe\u5b9f<\/h2>\n\n

\n \u3053\u308c\u3089\u306e\u6d3b\u6027\u6210\u5206\u3092\u7d71\u5408\u3059\u308b\u3053\u3068\u306f\u672c\u8cea\u7684\u306b\u56f0\u96e3\u3067\u3059\u3002\u88fd\u9020\u74b0\u5883\u306f\u53b3\u5bc6\u306b\u7ba1\u7406\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002 \n <\/p>\n\n

\n \u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306f\u5149\u3092\u5acc\u3044\u307e\u3059\u3002\u5bb9\u6613\u306b\u5206\u89e3\u3057\u307e\u3059\u3002\u9077\u79fb\u91d1\u5c5e\u306f\u6025\u901f\u306a\u9178\u5316\u3092\u5f15\u304d\u8d77\u3053\u3057\u307e\u3059\u3002\u88fd\u5264\u62c5\u5f53\u8005\u306f\u5f37\u529b\u306a\u9244\u30ad\u30ec\u30fc\u30c8\u5264\u3092\u4f7f\u7528\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u30b8\u30ca\u30c8\u30ea\u30a6\u30e0EDTA\u30920.05\u301c0.1%\u3067\u8003\u3048\u3066\u304f\u3060\u3055\u3044\u3002\u3053\u308c\u306b\u30c8\u30b3\u30d5\u30a7\u30ed\u30fc\u30eb\u306e\u3088\u3046\u306a\u5f37\u529b\u306a\u8102\u6eb6\u6027\u6297\u9178\u5316\u30b7\u30b9\u30c6\u30e0\u3092\u7d44\u307f\u5408\u308f\u305b\u307e\u3059\u3002\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306f\u6cb9\u76f8\u306b\u5165\u308c\u307e\u3059\u3002\u51b7\u5374\u4e2d\u306b40\u00b0C\u672a\u6e80\u3067\u6295\u5165\u3057\u307e\u3059\u3002 \u904e\u5ea6\u306e\u71b1\u306f\u6d3b\u6027\u5206\u5b50\u3092\u7834\u58ca\u3057\u307e\u3059\u3002<\/strong> \u6700\u7d42\u51e6\u65b9\u306epH\u3092\u53b3\u5bc6\u306b4.0\u304b\u30895.5\u306e\u9593\u306b\u4fdd\u3061\u307e\u3059\u3002\n <\/p>\n\n

\n PDRN\u306f\u3069\u3046\u3067\u3059\u304b\uff1f\u305d\u308c\u306f\u751f\u4f53\u9ad8\u5206\u5b50\u3067\u3059\u3002\u30ec\u30aa\u30ed\u30b8\u30fc\u304c\u6700\u5927\u306e\u8ab2\u984c\u3067\u3059\u3002\u9ad8\u305b\u3093\u65ad\u6df7\u5408\u3092\u4f7f\u7528\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 3000 RPM\u3092\u8d85\u3048\u308b\u30db\u30e2\u30b8\u30ca\u30a4\u30b6\u30fc\u306f\u3001DNA\u65ad\u7247\u3092\u7269\u7406\u7684\u306b\u305b\u3093\u65ad\u3057\u307e\u3059\u3002<\/strong> \u5206\u5b50\u91cf\u3092\u4f4e\u4e0b\u3055\u305b\u307e\u3059\u3002\u53d7\u5bb9\u4f53\u89aa\u548c\u6027\u3092\u5931\u3044\u307e\u3059\u3002\u5468\u56f2\u6e29\u5ea6\u3067\u6c34\u76f8\u306b\u6df7\u5408\u3057\u307e\u3059\u3002pH\u30925.5\u4ee5\u4e0a\u306b\u4fdd\u3061\u307e\u3059\u3002\u9178\u6027\u74b0\u5883\u306fDNA\u306e\u8131\u30d7\u30ea\u30f3\u3092\u5f15\u304d\u8d77\u3053\u3057\u307e\u3059\u3002\u69cb\u9020\u5d29\u58ca\u304c\u7d9a\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u5f37\u529b\u306a\u30ab\u30c1\u30aa\u30f3\u6027\u30dd\u30ea\u30de\u30fc\u304b\u3089\u9060\u3056\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u8ca0\u306b\u5e2f\u96fb\u3057\u305f\u30dd\u30ea\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u9396\u306f\u5373\u5ea7\u306b\u6c88\u6bbf\u3057\u307e\u3059\u3002\n <\/p>\n\n

\u76f8\u4e57\u30de\u30c8\u30ea\u30c3\u30af\u30b9\uff1a\u73fe\u5728\u306e\u88fd\u5264\u30c8\u30ec\u30f3\u30c9<\/h2>\n\n

\n \u5358\u4e00\u6210\u5206\u306e\u51e6\u65b9\u306f\u6025\u901f\u306b\u8870\u9000\u3057\u3066\u3044\u307e\u3059\u3002\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u306f\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u4fee\u5fa9\u30fb\u523a\u6fc0\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u3092\u8981\u6c42\u3057\u3066\u3044\u307e\u3059\u3002 \n <\/p>\n\n

\n \u30de\u30c8\u30ea\u30c3\u30af\u30b9A\uff1a\u690d\u7269\u7531\u6765\u30ec\u30c1\u30ce\u30fc\u30eb\uff0b\u30d0\u30ea\u30a2\u9632\u5fa1<\/strong>
\n \u30d0\u30af\u30c1\u30aa\u30fc\u30eb\uff080.5\u301c1.0%\uff09\u3068\u30b0\u30ea\u30c1\u30eb\u30ea\u30c1\u30f3\u9178\u30b8\u30ab\u30ea\u30a6\u30e0\uff080.1\u301c0.2%\uff09\u304a\u3088\u3073\u7d14\u7c8b\u306a\u30b9\u30af\u30ef\u30e9\u30f3\u3092\u7d44\u307f\u5408\u308f\u305b\u307e\u3059\u3002\u3053\u306eW\/O\u30a8\u30de\u30eb\u30b8\u30e7\u30f3\u306f\u3001\u69cb\u9020\u7684\u306a\u5149\u8001\u5316\u3092\u6a19\u7684\u3068\u3057\u307e\u3059\u3002\u540c\u6642\u306b\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\u306e\u7d05\u6591\u3092\u6291\u5236\u3057\u307e\u3059\u3002\u30b0\u30ea\u30c1\u30eb\u30ea\u30c1\u30f3\u9178\u30b8\u30ab\u30ea\u30a6\u30e0\u306f\u30d2\u30a2\u30eb\u30ed\u30cb\u30c0\u30fc\u30bc\u3092\u963b\u5bb3\u3057\u307e\u3059\u3002\u708e\u75c7\u6027\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u3092\u30c0\u30a6\u30f3\u30ec\u30ae\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3057\u307e\u3059\u3002\u3053\u306e\u76f8\u4e57\u52b9\u679c\u306f\u3001\u9152\u3055\u69d8\u76ae\u819a\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6301\u3064\u9ad8\u5ea6\u306b\u904e\u654f\u306a\u808c\u306b\u5bfe\u3059\u308b\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306e\u8010\u5bb9\u6027\u3092\u6700\u9069\u5316\u3057\u307e\u3059\u3002\n <\/p>\n\n

\n \u30de\u30c8\u30ea\u30c3\u30af\u30b9B\uff1a\u751f\u4f53\u6a21\u5023\u7d44\u7e54\u518d\u751f<\/strong>
\n \u8853\u5f8c\u30b1\u30a2\u306b\u306f\u7d76\u5bfe\u7684\u306a\u30b9\u30d4\u30fc\u30c9\u304c\u5fc5\u8981\u3067\u3059\u3002PDRN\uff080.5\u301c1.0%\uff09\u3068\u30a2\u30b7\u30a2\u30c1\u30b3\u30b7\u30c9\uff080.3%\uff09\u3092\u52a0\u6c34\u5206\u89e3\u30d2\u30a2\u30eb\u30ed\u30f3\u9178\u30ca\u30c8\u30ea\u30a6\u30e0\u30d9\u30fc\u30b9\u3067\u7d44\u307f\u5408\u308f\u305b\u307e\u3059\u3002\u3053\u306e\u30cf\u30a4\u30c9\u30ed\u30b2\u30eb\u306f\u3001\u4fb5\u8972\u6027\u30ec\u30fc\u30b6\u30fc\u307e\u305f\u306f\u30de\u30a4\u30af\u30ed\u30cb\u30fc\u30c9\u30ea\u30f3\u30b0\u5f8c\u306e\u8fc5\u901f\u306a\u30d0\u30ea\u30a2\u56de\u5fa9\u3092\u6a19\u7684\u3068\u3057\u307e\u3059\u3002PDRN\u306fVEGF\u8840\u7ba1\u65b0\u751f\u523a\u6fc0\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u30bb\u30f3\u30c6\u30e9\u30a8\u30ad\u30b9\u306f\u8fc5\u901f\u306a\u30b3\u30e9\u30fc\u30b2\u30f3\u5408\u6210\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002 \n <\/p>\n\n

\u898f\u5236\u304a\u3088\u3073\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u72b6\u6cc1<\/h2>\n\n

\n \u30b0\u30ed\u30fc\u30d0\u30eb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306f\u3001\u5fae\u91cf\u6c5a\u67d3\u7269\u8cea\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306f\u304b\u3089\u62bd\u51fa\u3055\u308c\u307e\u3059 \u30aa\u30e9\u30f3\u30c0\u30d3\u30e6<\/i>\u3002\u3053\u308c\u306f\u3001\u5149\u6bd2\u6027\u306e\u3042\u308b\u30bd\u30e9\u30ec\u30f3\u3092\u5171\u62bd\u51fa\u3059\u308b\u30ea\u30b9\u30af\u304c\u81ea\u7136\u306b\u3042\u308a\u307e\u3059\u3002 \u9ad8\u30b0\u30ec\u30fc\u30c9\u306e\u6750\u6599\u306f\u3001\u30bd\u30e9\u30ec\u30f3\u30ec\u30d9\u30eb\u304c1 ppm\u672a\u6e80\u3067\u3042\u308b\u3053\u3068\u3092\u8a3c\u660e\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> \u3053\u308c\u306f\u3001EU\u306e\u65e5\u4e2d\u306e\u5316\u7ca7\u54c1\u5b89\u5168\u30de\u30fc\u30b8\u30f3\u3092\u6e80\u305f\u3059\u305f\u3081\u306b\u5fc5\u9808\u3067\u3059\u3002\u5316\u7ca7\u54c1\u30b0\u30ec\u30fc\u30c9\u306ePDRN\u306f\u9bad\u306e\u767d\u5b50\u304b\u3089\u4f5c\u3089\u308c\u307e\u3059\u3002\u53b3\u683c\u306a\u30a6\u30a4\u30eb\u30b9\u9664\u53bb\u8a66\u9a13\u306f\u4ea4\u6e09\u306e\u4f59\u5730\u304c\u3042\u308a\u307e\u305b\u3093\u3002\u30a2\u30ec\u30eb\u30ae\u30fc\u53cd\u5fdc\u3092\u8efd\u6e1b\u3059\u308b\u305f\u3081\u306b\u3001\u5305\u62ec\u7684\u306a\u30bf\u30f3\u30d1\u30af\u8cea\u6b8b\u6e23\u9664\u53bb\u304c\u5fc5\u8981\u3067\u3059\u3002\u3069\u3061\u3089\u3082\u53b3\u683c\u306aEU REACH\u539f\u6750\u6599\u5b89\u5168\u8a55\u4fa1\u3092\u30af\u30ea\u30a2\u3059\u308b\u305f\u3081\u306b\u5fc5\u8981\u3067\u3059\u3002\n <\/p>\n\n

B2B\u30bd\u30fc\u30b7\u30f3\u30b0FAQ\uff1a8\u3064\u306e\u9ad8\u983b\u5ea6\u88fd\u5264\u30af\u30a8\u30ea<\/h2>\n \n
    \n
  1. 99%\u7d14\u5ea6\u306e\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u3068\u5316\u7ca7\u54c1\u30b0\u30ec\u30fc\u30c9\u306ePDRN\u30d0\u30eb\u30af\u30d1\u30a6\u30c0\u30fc\u306e\u9593\u306e\u6a19\u6e96\u7684\u306a\u5378\u58f2\u4fa1\u683c\u306e\u5909\u52d5\u306f\u4f55\u306b\u3088\u3063\u3066\u99c6\u52d5\u3055\u308c\u307e\u3059\u304b\uff1f<\/strong>
    \u4fa1\u683c\u8a2d\u5b9a\u306f\u62bd\u51fa\u306e\u8907\u96d1\u3055\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306b\u306f\u9ad8\u6027\u80fd\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u30fc\uff08HPLC\uff09\u7cbe\u88fd\u304c\u5fc5\u8981\u3067\u3059\u304c\u3001PDRN\u306b\u306f\u9ad8\u4fa1\u306a\u9175\u7d20\u5207\u65ad\u3068\u30a6\u30a4\u30eb\u30b9\u9664\u53bb\u304c\u5fc5\u8981\u3067\u3059\u3002<\/li>\n
  2. \u5f53\u793e\u306e\u793e\u5185QC\u30e9\u30dc\u306f\u3001\u5408\u6210\u6df7\u5165\u3092\u78ba\u5b9f\u306b\u9664\u5916\u3059\u308b\u305f\u3081\u306b\u3001\u690d\u7269\u7531\u6765\u306e\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306e\u7d14\u5ea6\u3092\u3069\u306e\u3088\u3046\u306b\u691c\u8a3c\u3067\u304d\u307e\u3059\u304b\uff1f<\/strong>
    C14\u653e\u5c04\u6027\u70ad\u7d20\u5e74\u4ee3\u6e2c\u5b9a\u3092\u4f7f\u7528\u3057\u3066\u751f\u7269\u5b66\u7684\u8d77\u6e90\u3092\u78ba\u8a8d\u3057\u3001HPLC\u3068\u7d44\u307f\u5408\u308f\u305b\u3066\u5408\u6210\u6eb6\u5a92\u6b8b\u6e23\u3092\u30c1\u30a7\u30c3\u30af\u3057\u307e\u3059\u3002<\/li>\n
  3. \u6c34\u6eb6\u6027PDRN\u306f\u3001\u7121\u6c34\u30aa\u30a4\u30eb\u30bb\u30e9\u30e0\u306b\u6b63\u5e38\u306b\u61f8\u6fc1\u3067\u304d\u307e\u3059\u304b\uff1f<\/strong>
    \u306f\u3044\u3001\u305f\u3060\u3057\u3001\u76f8\u5206\u96e2\u3092\u9632\u3050\u305f\u3081\u306b\u306f\u9ad8\u5ea6\u306a\u30ea\u30dd\u30bd\u30fc\u30e0\u30ab\u30d7\u30bb\u30eb\u5316\u307e\u305f\u306f\u7279\u5b9a\u306e\u30de\u30a4\u30af\u30ed\u30a8\u30de\u30eb\u30b8\u30e7\u30f3\u6280\u8853\u304c\u5fc5\u8981\u3067\u3059\u3002<\/li>\n
  4. PDRN\u7d44\u7e54\u518d\u751f\u52b9\u679c\u306e\u30c6\u30b9\u30c8\u306b\u63a8\u5968\u3055\u308c\u308b\u6700\u5c0f\u6d3b\u6027\u7528\u91cf\u306f\u3044\u304f\u3089\u3067\u3059\u304b\uff1f<\/strong>
    \u81e8\u5e8a\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\u3067\u306f\u3001\u65e5\u5e38\u4f7f\u7528\u5316\u7ca7\u54c1\u306e\u5834\u5408\u306f0.5%\u304b\u3089\u3001\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u306a\u30ec\u30fc\u30b6\u30fc\u5f8c\u30b1\u30a2\u30cf\u30a4\u30c9\u30ed\u30b2\u30eb\u3067\u306f\u6700\u59272.0%\u304b\u3089\u958b\u59cb\u3059\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002<\/li>\n
  5. \u9ad8\u5206\u5b50\u91cf\u306e\u5316\u7ca7\u54c1PDRN\u306f\u3001\u8f38\u9001\u4e2d\u306b\u7279\u5225\u306a\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u7269\u6d41\u3092\u5fc5\u8981\u3068\u3057\u307e\u3059\u304b\uff1f<\/strong>
    \u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\u306f\u5ba4\u6e29\u3067\u5b89\u5b9a\u3067\u3059\u304c\u3001\u6d77\u4e0a\u8f38\u9001\u4e2d\u306b45\u2103\u3092\u8d85\u3048\u308b\u6e29\u5ea6\u306b\u9577\u6642\u9593\u3055\u3089\u3055\u308c\u308b\u3068\u69cb\u9020\u52a3\u5316\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n
  6. \u30d5\u30a9\u30fc\u30df\u30e5\u30ec\u30fc\u30bf\u30fc\u306f\u3001\u9ad8\u6c34\u5206\u542b\u6709\u30ed\u30fc\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306e\u6bb5\u968e\u7684\u306a\u9ec4\u5909\u554f\u984c\u3092\u3069\u306e\u3088\u3046\u306b\u89e3\u6c7a\u3057\u307e\u3059\u304b\uff1f<\/strong>
    \u30c7\u30e5\u30a2\u30eb\u6297\u9178\u5316\u6226\u7565\uff08\u4f8b\uff1a0.1% BHT + 0.2% \u30d3\u30bf\u30df\u30f3E\uff09\u3092\u5b9f\u88c5\u3057\u3001\u4e0d\u900f\u660e\u306a\u30a8\u30a2\u30ec\u30b9\u30dd\u30f3\u30d7\u30dc\u30c8\u30eb\u306b\u53b3\u5bc6\u306b\u30d1\u30c3\u30b1\u30fc\u30b8\u5316\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/li>\n
  7. \u30b5\u30fc\u30e2\u30f3\u7531\u6765\u306ePDRN\u3092\u6b27\u5dde\u9023\u5408\u306b\u8f38\u5165\u3059\u308b\u969b\u306b\u3001\u7279\u5b9a\u306e\u898f\u5236\u4e0a\u306e\u30cf\u30fc\u30c9\u30eb\u306f\u3042\u308a\u307e\u3059\u304b\uff1f<\/strong>
    EU\u5316\u7ca7\u54c1\u898f\u5236\u306e\u4e0b\u3067\u3001\u53b3\u683c\u306aTSE\/BSE\u30d5\u30ea\u30fc\u8a8d\u8a3c\u304a\u3088\u3073\u30a2\u30ec\u30eb\u30b2\u30f3\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\uff08\u7279\u306b\u9b5a\u30bf\u30f3\u30d1\u30af\u8cea\u306b\u95a2\u3057\u3066\uff09\u3092\u901a\u904e\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n
  8. PDRN\u30d5\u30e9\u30b0\u30e1\u30f3\u30c8\u30b5\u30a4\u30ba\u3092\u5b9a\u91cf\u5316\u3059\u308b\u305f\u3081\u306b\u3001\u3069\u306e\u7b2c\u4e09\u8005\u5206\u6790\u65b9\u6cd5\u304c\u696d\u754c\u6a19\u6e96\u3068\u898b\u306a\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/strong>
    \u30b2\u30eb\u6d78\u900f\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u30fc\uff08GPC\uff09\u3068\u591a\u89d2\u5ea6\u5149\u6563\u4e71\uff08MALS\uff09\u306e\u7d44\u307f\u5408\u308f\u305b\u306f\u3001\u6700\u3082\u6b63\u78ba\u306a\u5206\u5b50\u91cf\u5206\u5e03\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/li>\n <\/ol>\n<\/div>","protected":false},"excerpt":{"rendered":"

    \u76ae\u819a\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u306e\u518d\u69cb\u7bc9\u306f\u5f53\u3066\u305a\u3063\u307d\u3046\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u305d\u308c\u306f\u7279\u5b9a\u306e\u751f\u5316\u5b66\u7684\u7d4c\u8def\u306b\u4f9d\u5b58\u3057\u3066\u3044\u307e\u3059\u3002\u6d3b\u6027\u5206\u5b50\u3092\u5c0e\u5165\u3059\u308b\u3068\u3001\u76ae\u819a\u304c\u53cd\u5fdc\u3057\u307e\u3059\u3002\u30d0\u30af\u30c1\u30aa\u30fc\u30eb\u306f\u30ec\u30c1\u30ce\u30fc\u30eb\u3092\u6a21\u5023\u3057\u307e\u3059\u3002PDRN\u306f\u518d\u751f\u3057\u307e\u3059\u2026<\/p>","protected":false},"author":1,"featured_media":15246,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-15245","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-updates"],"yoast_head":"\nBakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters - Shaanxi Huatai Bio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters\" \/>\n<meta property=\"og:description\" content=\"Dermal matrix reconstruction is not guesswork. It relies on specific biochemical pathways. You introduce an active molecule. The skin reacts. Bakuchiol mimics retinol. PDRN regenerates...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\" \/>\n<meta property=\"og:site_name\" content=\"Shaanxi Huatai Bio\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-22T09:32:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-22T09:33:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"572\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"liuhana978@gmail.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"liuhana978@gmail.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\"},\"author\":{\"name\":\"liuhana978@gmail.com\",\"@id\":\"https:\/\/www.totarolchina.com\/es\/#\/schema\/person\/f527e330ba607dc584aa38354b43e9ed\"},\"headline\":\"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters\",\"datePublished\":\"2026-09-22T09:32:59+00:00\",\"dateModified\":\"2026-09-22T09:33:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\"},\"wordCount\":897,\"publisher\":{\"@id\":\"https:\/\/www.totarolchina.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg\",\"articleSection\":[\"Product Updates\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\",\"url\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\",\"name\":\"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters - Shaanxi Huatai Bio\",\"isPartOf\":{\"@id\":\"https:\/\/www.totarolchina.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg\",\"datePublished\":\"2026-09-22T09:32:59+00:00\",\"dateModified\":\"2026-09-22T09:33:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage\",\"url\":\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg\",\"contentUrl\":\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg\",\"width\":1024,\"height\":572,\"caption\":\"BAKUCHIOL VS PDRN\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.totarolchina.com\/ja\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.totarolchina.com\/es\/#website\",\"url\":\"https:\/\/www.totarolchina.com\/es\/\",\"name\":\"Shaanxi Huatai Bio\",\"description\":\"Huatai Bio empowers global skincare brands by supplying top-tier cosmetic actives that prioritize safety and performance. Our extensive portfolio, backed by ISO, COSMOS, and HALAL quality standards, provides the essential building blocks for innovative beauty formulations. Explore our range of compliant, high-efficacy ingredients designed to elevate your skincare line.\",\"publisher\":{\"@id\":\"https:\/\/www.totarolchina.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.totarolchina.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.totarolchina.com\/es\/#organization\",\"name\":\"Shaanxi Huatai Bio\",\"url\":\"https:\/\/www.totarolchina.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.totarolchina.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/03\/LOGO-300x184-1.webp\",\"contentUrl\":\"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/03\/LOGO-300x184-1.webp\",\"width\":300,\"height\":184,\"caption\":\"Shaanxi Huatai Bio\"},\"image\":{\"@id\":\"https:\/\/www.totarolchina.com\/es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.totarolchina.com\/es\/#\/schema\/person\/f527e330ba607dc584aa38354b43e9ed\",\"name\":\"liuhana978@gmail.com\",\"sameAs\":[\"http:\/\/totarolchina.com\"],\"url\":\"https:\/\/www.totarolchina.com\/ja\/author\/liuhana978gmail-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters - Shaanxi Huatai Bio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/","og_locale":"ja_JP","og_type":"article","og_title":"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters","og_description":"Dermal matrix reconstruction is not guesswork. It relies on specific biochemical pathways. You introduce an active molecule. The skin reacts. Bakuchiol mimics retinol. PDRN regenerates...","og_url":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/","og_site_name":"Shaanxi Huatai Bio","article_published_time":"2026-09-22T09:32:59+00:00","article_modified_time":"2026-09-22T09:33:00+00:00","og_image":[{"width":1024,"height":572,"url":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg","type":"image\/jpeg"}],"author":"liuhana978@gmail.com","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"liuhana978@gmail.com","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"5\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#article","isPartOf":{"@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/"},"author":{"name":"liuhana978@gmail.com","@id":"https:\/\/www.totarolchina.com\/es\/#\/schema\/person\/f527e330ba607dc584aa38354b43e9ed"},"headline":"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters","datePublished":"2026-09-22T09:32:59+00:00","dateModified":"2026-09-22T09:33:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/"},"wordCount":897,"publisher":{"@id":"https:\/\/www.totarolchina.com\/es\/#organization"},"image":{"@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage"},"thumbnailUrl":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg","articleSection":["Product Updates"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/","url":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/","name":"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters - Shaanxi Huatai Bio","isPartOf":{"@id":"https:\/\/www.totarolchina.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage"},"image":{"@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage"},"thumbnailUrl":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg","datePublished":"2026-09-22T09:32:59+00:00","dateModified":"2026-09-22T09:33:00+00:00","breadcrumb":{"@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#primaryimage","url":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg","contentUrl":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/09\/BAKUCHIOL-VS-PDRN.jpeg","width":1024,"height":572,"caption":"BAKUCHIOL VS PDRN"},{"@type":"BreadcrumbList","@id":"https:\/\/www.totarolchina.com\/ja\/bakuchiol-vs-pdrn-clinical-efficacy-and-formulation-parameters\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.totarolchina.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Bakuchiol vs PDRN: Clinical Efficacy and Formulation Parameters"}]},{"@type":"WebSite","@id":"https:\/\/www.totarolchina.com\/es\/#website","url":"https:\/\/www.totarolchina.com\/es\/","name":"Shaanxi Huatai Bio","description":"Huatai Bio empowers global skincare brands by supplying top-tier cosmetic actives that prioritize safety and performance. Our extensive portfolio, backed by ISO, COSMOS, and HALAL quality standards, provides the essential building blocks for innovative beauty formulations. Explore our range of compliant, high-efficacy ingredients designed to elevate your skincare line.","publisher":{"@id":"https:\/\/www.totarolchina.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.totarolchina.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/www.totarolchina.com\/es\/#organization","name":"Shaanxi Huatai Bio","url":"https:\/\/www.totarolchina.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.totarolchina.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/03\/LOGO-300x184-1.webp","contentUrl":"https:\/\/www.totarolchina.com\/wp-content\/uploads\/2026\/03\/LOGO-300x184-1.webp","width":300,"height":184,"caption":"Shaanxi Huatai Bio"},"image":{"@id":"https:\/\/www.totarolchina.com\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.totarolchina.com\/es\/#\/schema\/person\/f527e330ba607dc584aa38354b43e9ed","name":"liuhana978@gmail.com","sameAs":["http:\/\/totarolchina.com"],"url":"https:\/\/www.totarolchina.com\/ja\/author\/liuhana978gmail-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/posts\/15245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/comments?post=15245"}],"version-history":[{"count":1,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/posts\/15245\/revisions"}],"predecessor-version":[{"id":15247,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/posts\/15245\/revisions\/15247"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/media\/15246"}],"wp:attachment":[{"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/media?parent=15245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/categories?post=15245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.totarolchina.com\/ja\/wp-json\/wp\/v2\/tags?post=15245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}